In Pursuit of Value-Based Drug Prices in the US: New York and Beyond
Liam Bendicksen July 30, 2020
Today, rising brand-name prescription drug prices (and increasingly-prevalent high-deductible health plans) pose a threat to Americans’ financial security and to the health of our communities. Past political controversies notwithstanding, using cost-effectiveness research and analyses to pay for high-value prescription drugs can help US patients afford the drugs they need as prices continue to rise.
